
Friedreich’s ataxia: ‘We haven’t got time. We just simply need a chance’
Patients and families are calling on the HSE to fund Skyclarys, a treatment they say could help slow progression of the rare disease

Patients and families are calling on the HSE to fund Skyclarys, a treatment they say could help slow progression of the rare disease